UBS AM’s Sagimet Biosciences SGMT Stock Holding History
Bought
Maintained
Sold
Other funds holding SGMT
SVCM
UBS AM's SGMT Position: Q3 2026 in Review
UBS AM opened a new position in Sagimet Biosciences (SGMT) in Q3 2026: 495 shares worth $4.89K. The stake represents ﹤0.01% of the portfolio and ranks #3911 among its holdings.
128 funds tracked by Wall St. Rank hold SGMT as of Q3 2026.
- UBS AM held 495 shares of Sagimet Biosciences worth $4.89K as of Q3 2026.
- Sagimet Biosciences was a new UBS AM position in Q3 2026.
- Sagimet Biosciences made up ﹤0.01% of UBS AM's portfolio in Q3 2026, its #3911 holding.
- 128 funds tracked by Wall St. Rank held Sagimet Biosciences as of Q3 2026.
Based on UBS AM's 13F filing for Q3 2026, filed 16 Nov 2026.